# Intravenous Milk Thistle (Silibinin-Legalon) for Hepatic Failure Induced by Amatoxin/Amanita Mushroom Poisoning

> **NCT00915681** · PHASE2 · TERMINATED · sponsor: **Mylan Specialty, LP** · enrollment: 148 (actual)

## Conditions studied

- Amatoxin Poisoning
- Amanita Poisoning
- Mushroom Poisoning
- Liver Failure

## Interventions

- **DRUG:** Silibinin

## Key facts

- **NCT ID:** NCT00915681
- **Lead sponsor:** Mylan Specialty, LP
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-11-10
- **Primary completion:** 2020-04-10
- **Final completion:** 2020-04-10
- **Target enrollment:** 148 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2022-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00915681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00915681, "Intravenous Milk Thistle (Silibinin-Legalon) for Hepatic Failure Induced by Amatoxin/Amanita Mushroom Poisoning". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00915681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*